News

What Does the Market Think About Globus Medical?
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
Investor's Business Daily on MSN1d
Globus Medical Sees Relative Strength Rating Improve To 73
Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
GlobeSt1d
Medical Outpatient Buildings See Sales Drop 44% in Q1
Nationwide MOB sales were $1.5 billion in Q1. That was down 44% from Q4 2024. It marks the lowest quarter MOB sales since Q3 ...
StockStory.org on MSN1d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?
Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
American Association of Individual Investors2d
Which Is a Better Investment, Globus Medical, Inc. or LeMaitre Vascular, Inc. Stock?
Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Globus Medical: Digesting Another Acquisition
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.